14-day Premium Trial Subscription Sign Up For FreeGet Free

When Should You SELL Your Stocks? Click to watch.

CTI BioPharma Corp. Stock Forecast

NASDAQ:CTIC BUY SELL

$4.87 (9.93%)

Volume: 3.022M

Closed: May 19, 2022

Hollow Logo Score: -0.070

CTI BioPharma Corp. Stock Forecast

BUY SELL NASDAQ:CTIC
$4.87 (9.93%)

Volume: 3.022M

Closed: May 19, 2022

Score Hollow Logo -0.070

CTI BioPharma Corp. Stock Forecast NASDAQ:CTIC

Price Target and Analyst Ratings

Historical Ratings

Date Upside / Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
2022-03-02 2.67% JMP Securities $4.00 $5.00 Maintains Market Outperform
2022-03-02 64.27% Needham $5.00 $8.00 Maintains Buy
2021-12-01 2.67% Needham $6.00 $5.00 Maintains Buy
2021-08-09 43.74% BTIG $7.00 Initiates Coverage On Buy
2021-05-06 12.94% Stifel $5.50 Initiates Coverage On Buy
2020-10-23 43.74% Brookline Capital $7.00 Initiates Coverage On Buy
2020-09-30 23.2% Needham $3.50 $6.00 Maintains Buy

CTIC Stock Trend

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled.

Given the current short-term trend, the stock is expected to rise 34.58% during the next 3 months and, with a 90% probability hold a price between $4.47 and $7.98 at the end of this 3-month period.

Data

Date Bottom Mid Top
2022-05-23 $3.35 $4.65 $5.95
2022-05-24 $3.37 $4.68 $5.98
2022-05-25 $3.40 $4.70 $6.00
2022-05-26 $3.42 $4.73 $6.03
2022-05-27 $3.45 $4.75 $6.05
2022-05-31 $3.47 $4.78 $6.08
2022-06-01 $3.50 $4.80 $6.10
2022-06-02 $3.52 $4.83 $6.13
2022-06-03 $3.55 $4.85 $6.15
2022-06-06 $3.57 $4.88 $6.18
2022-06-07 $3.60 $4.90 $6.20
2022-06-08 $3.62 $4.93 $6.23
2022-06-09 $3.65 $4.95 $6.25
2022-06-10 $3.67 $4.98 $6.28
2022-06-13 $3.70 $5.00 $6.30
2022-06-14 $3.72 $5.03 $6.33
2022-06-15 $3.75 $5.05 $6.35
2022-06-16 $3.77 $5.08 $6.38
2022-06-17 $3.80 $5.10 $6.40
2022-06-21 $3.82 $5.13 $6.43
2022-06-22 $3.85 $5.15 $6.45
2022-06-23 $3.87 $5.18 $6.48
2022-06-24 $3.90 $5.20 $6.50
2022-06-27 $3.92 $5.23 $6.53
2022-06-28 $3.95 $5.25 $6.55
2022-06-29 $3.97 $5.28 $6.58
2022-06-30 $4.00 $5.30 $6.60
2022-07-01 $4.02 $5.33 $6.63
2022-07-05 $4.05 $5.35 $6.65
2022-07-06 $4.07 $5.38 $6.68

About CTI BioPharma Corp.

CTI BioPharma CTI BioPharma Corp., a biopharmaceutical company, engages in the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States and internationally. It primarily focuses on the commercialization of PIXUVRI, an aza-anthracenedione for the treatment of adult patients with multiply relapsed or refractory aggressive B-cell non-Hodgkin lymphoma in the European Union. The company is also devel... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!
.

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT